Advanced Medical Solutions Group 향후 성장

Future 기준 점검 4/6

Advanced Medical Solutions Group (는) 각각 연간 30.5% 및 6.4% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 29.7% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 12.9% 로 예상됩니다.

핵심 정보

30.5%

이익 성장률

29.70%

EPS 성장률

Medical Equipment 이익 성장	16.2%
매출 성장률	6.4%
향후 자기자본이익률	12.86%
애널리스트 커버리지	Good
마지막 업데이트	29 Sep 2025

최근 향후 성장 업데이트

Here's What Analysts Are Forecasting For Advanced Medical Solutions Group plc (LON:AMS) After Its Interim Results

Sep 21

Recent updates

Here's What Analysts Are Forecasting For Advanced Medical Solutions Group plc (LON:AMS) After Its Interim Results

Sep 21

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Advanced Medical Solutions Group plc's (LON:AMS) CEO For Now

Jun 23

What You Can Learn From Advanced Medical Solutions Group plc's (LON:AMS) P/E After Its 25% Share Price Crash

Apr 27

There May Be Some Bright Spots In Advanced Medical Solutions Group's (LON:AMS) Earnings

Mar 28

Investors Could Be Concerned With Advanced Medical Solutions Group's (LON:AMS) Returns On Capital

Jan 15

Advanced Medical Solutions Group plc's (LON:AMS) Popularity With Investors Is Under Threat From Overpricing

Nov 18

A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)

Sep 07

Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?

Nov 03

Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate

Sep 05

Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends

Dec 03

Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?

Sep 03

Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business

Aug 05

An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued

May 31

Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital

Apr 23

Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively

Jan 08

A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)

Nov 24

Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital

May 22

A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)

Apr 10

Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 20

Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?

Feb 28

The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come

Feb 07

Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Jan 18

이익 및 매출 성장 예측

AIM:AMS - 애널리스트 향후 추정치 및 과거 재무 데이터 (GBP Millions)
날짜	매출	이익	자유현금흐름	영업현금흐름	평균 애널리스트 수
12/31/2027	262	26	33	48	7
12/31/2026	244	13	22	41	7
12/31/2025	228	13	19	44	7
6/30/2025	220	9	19	28	N/A
3/31/2025	199	8	15	24	N/A
12/31/2024	178	7	11	19	N/A
9/30/2024	154	9	9	17	N/A
6/30/2024	131	11	6	15	N/A
3/31/2024	129	14	4	14	N/A
12/31/2023	126	16	2	12	N/A
9/30/2023	128	18	5	15	N/A
6/30/2023	129	20	8	18	N/A
3/31/2023	127	20	12	23	N/A
12/31/2022	124	20	17	27	N/A
9/30/2022	121	19	19	28	N/A
6/30/2022	117	18	22	30	N/A
3/31/2022	113	18	23	30	N/A
12/31/2021	109	17	25	31	N/A
9/30/2021	103	16	23	29	N/A
6/30/2021	98	14	21	26	N/A
3/31/2021	92	11	18	24	N/A
12/31/2020	87	9	16	22	N/A
9/30/2020	90	11	15	21	N/A
6/30/2020	93	14	15	20	N/A
3/31/2020	98	16	15	21	N/A
12/31/2019	102	19	16	22	N/A
9/30/2019	103	20	15	20	N/A
6/30/2019	104	21	14	19	N/A
3/31/2019	103	22	N/A	20	N/A
1/1/2019	103	22	N/A	22	N/A
9/30/2018	101	22	N/A	N/A	N/A
6/30/2018	98	22	N/A	23	N/A
3/31/2018	98	21	N/A	20	N/A
12/31/2017	97	20	N/A	17	N/A
9/30/2017	94	19	N/A	N/A	N/A
6/30/2017	90	17	N/A	18	N/A
3/31/2017	87	17	N/A	19	N/A
12/31/2016	83	16	N/A	20	N/A
9/30/2016	79	15	N/A	N/A	N/A
6/30/2016	75	15	N/A	23	N/A
3/31/2016	72	14	N/A	22	N/A
12/31/2015	69	14	N/A	21	N/A
9/30/2015	67	14	N/A	19	N/A
6/30/2015	66	14	N/A	18	N/A
3/31/2015	65	13	N/A	17	N/A
12/31/2014	63	13	N/A	17	N/A

애널리스트 향후 성장 전망

수입 대 저축률: AMS 의 연간 예상 수익 증가율(30.5%)이 saving rate(2.7%)보다 높습니다.

수익 vs 시장: AMS 의 연간 수익(30.5%)이 UK 시장(14.2%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 수익: AMS 의 수입은 향후 3년 동안 상당히 증가할 것으로 예상됩니다.

수익 대 시장: AMS 의 수익(연간 6.4%)이 UK 시장(연간 4.2%)보다 빠르게 성장할 것으로 예상됩니다.

고성장 매출: AMS 의 수익(연간 6.4%)은 연간 20%보다 느리게 증가할 것으로 예상됩니다.

주당순이익 성장 예측

향후 자기자본이익률

미래 ROE: AMS의 자본 수익률은 3년 후 12.9%로 낮을 것으로 예상됩니다.

성장 기업 찾아보기

기업 분석 및 재무 데이터 상태

데이터	최종 업데이트 (UTC 시간)
기업 분석	2025/10/06 08:56
종가	2025/10/03 00:00
수익	2025/06/30
연간 수익	2024/12/31

데이터 소스

당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.

패키지	데이터	기간	미국 소스 예시 ^*
기업 재무제표	10년	손익계산서 현금흐름표 대차대조표	SEC 양식 10-K SEC 양식 10-Q
분석가 컨센서스 추정치	+3년	재무 예측 분석가 목표주가	분석가 리서치 보고서 Blue Matrix
시장 가격	30년	주가 배당, 분할 및 기타 조치	ICE 시장 데이터 SEC 양식 S-1
지분 구조	10년	주요 주주 내부자 거래	SEC 양식 4 SEC 양식 13D
경영진	10년	리더십 팀 이사회	SEC 양식 10-K SEC 양식 DEF 14A
주요 개발	10년	회사 공시	SEC 양식 8-K

^* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.

별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.

분석 모델 및 스노우플레이크

이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 Github 페이지에서 확인할 수 있으며, 보고서 활용 방법에 대한 가이드와 Youtube 튜토리얼도 제공합니다.

Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.

산업 및 섹터 지표

산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.

분석가 소스

Advanced Medical Solutions Group plc는 22명의 분석가가 다루고 있습니다. 이 중 7명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.

분석가	기관
Samuel England	Berenberg
Julie Simmonds	Canaccord Genuity
Keith Redpath	Cavendish

Advanced Medical Solutions Group 향후 성장

Future 기준 점검 4/6

핵심 정보

최근 향후 성장 업데이트

Consensus EPS estimates fall by 10%

Consensus EPS estimates increase by 18%

Here's What Analysts Are Forecasting For Advanced Medical Solutions Group plc (LON:AMS) After Its Interim Results

Consensus EPS estimates fall by 21%

Advanced Medical Solutions Group plc Provides Earnings Guidance for the First Half and Full Year 2024

Consensus EPS estimates fall by 17%, revenue upgraded

Recent updates

Consensus EPS estimates fall by 10%

CEO & Executive Director recently sold UK£110k worth of stock

Consensus EPS estimates increase by 18%

Here's What Analysts Are Forecasting For Advanced Medical Solutions Group plc (LON:AMS) After Its Interim Results

First half 2025 earnings released: EPS: UK£0.029 (vs UK£0.019 in 1H 2024)

Advanced Medical Solutions Group plc to Report First Half, 2025 Results on Sep 17, 2025

Advanced Medical Solutions Group plc Appoints Juliet Thompson as Non-Executive Director and Chair of the Audit Committee

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Advanced Medical Solutions Group plc's (LON:AMS) CEO For Now

Upcoming dividend of UK£0.018 per share

Full year 2024 earnings: EPS misses analyst expectations

CEO & Executive Director exercised options and sold UK£125k worth of stock

CEO & Executive Director recently sold UK£410k worth of stock

Advanced Medical Solutions Group plc, Annual General Meeting, Jun 30, 2025

Investor sentiment improves as stock rises 16%

What You Can Learn From Advanced Medical Solutions Group plc's (LON:AMS) P/E After Its 25% Share Price Crash

Advanced Medical Solutions Group plc Appoints Susan Searle as Non-Executive Director

Investor sentiment improves as stock rises 20%

There May Be Some Bright Spots In Advanced Medical Solutions Group's (LON:AMS) Earnings

New minor risk - Share price stability

Montagu Private Equity Responses to Press Speculation

Consensus EPS estimates fall by 21%

Final dividend increased to UK£0.018

New minor risk - Earnings quality

Advanced Medical Solutions Group plc Proposes Final Dividend for the Year Ended 31 December 2024, Payable on 20 June 2025

Advanced Medical Solutions Group plc Announces Board Changes

Investor sentiment improves as stock rises 18%

Investors Could Be Concerned With Advanced Medical Solutions Group's (LON:AMS) Returns On Capital

Advanced Medical Solutions Group plc to Report Fiscal Year 2024 Results on Mar 19, 2025

Advanced Medical Solutions Group plc's (LON:AMS) Popularity With Investors Is Under Threat From Overpricing

CFO & Executive Director exercised options and sold UK£74k worth of stock

Investor sentiment improves as stock rises 19%

First half 2024 earnings released: EPS: UK£0.019 (vs UK£0.041 in 1H 2023)

First half dividend increased to UK£0.0077

New minor risk - Profit margin trend

Advanced Medical Solutions Group plc Announces Interim Dividend, Payable on 25 October 2024

A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)

Advanced Medical Solutions Group plc to Report First Half, 2024 Results on Sep 18, 2024

Now 21% undervalued

Advanced Medical Solutions Group plc Provides Earnings Guidance for the First Half and Full Year 2024

New minor risk - Insider selling

Upcoming dividend of UK£0.017 per share

Advanced Medical Solutions Group plc, Annual General Meeting, Jun 12, 2024

Consensus EPS estimates fall by 17%, revenue upgraded

CEO & Executive Director recently bought UK£79k worth of stock

Advanced Medical Solutions Group plc (AIM:AMS) entered into an agreement to acquire Péters Surgical SASU from Eurazeo SE (ENXTPA:RF) and others for €140 million.

Final dividend increased to UK£0.017

Advanced Medical Solutions Group plc Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 21 June 2024

Full year 2023 earnings: EPS misses analyst expectations

Now 21% undervalued after recent price drop

Advanced Medical Solutions Group plc to Report Fiscal Year 2023 Results on Mar 13, 2024

Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?

Independent Non-Executive Director recently bought UK£100k worth of stock

First half 2023 earnings released: EPS: UK£0.041 (vs UK£0.045 in 1H 2022)

Advanced Medical Solutions Group plc Announces Interim Dividend, Payable on 27 October 2023

Investor sentiment deteriorates as stock falls 26%

Advanced Medical Solutions Group plc Provides Earnings Guidance for the Fiscal Year 2023

Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate

Price target decreased by 11% to UK£2.73

Now 21% undervalued after recent price drop

New major risk - Revenue and earnings growth

Advanced Medical Solutions Group plc to Report Q2, 2023 Results on Sep 20, 2023

Advanced Medical Solutions Group plc Receives Approval from the US Food and Drug Administration for the Pre-Market Approval of LiquiBandFix8 for Use in Hernia Surgery

Upcoming dividend of UK£0.015 per share at 0.9% yield

Investor sentiment deteriorates as stock falls 17%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Now 25% undervalued after recent price drop

Advanced Medical Solutions Group plc (AIM:AMS) acquired Connexicon Medical Ltd.

Advanced Medical Solutions Group plc to Report Fiscal Year 2022 Results on Mar 15, 2023

Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends